Table 1. Biochemical and biological activities of hits.
KD or Ki (µM) | % pGAB1 inhibition | IC50 (µM) | ||||
ID | GAB1 | IRS1 | AKT1 | MDA-MB-231 | T47D | |
GAB-001 | 9.38±1.60* | NB | ND | 55 | 40.3±1.3 | 23.7±2.7 |
GAB-002 | 2.1±0.1 | 16.4±4.3 | ND | 32 | 142.7±11.6 | 137.6±6.9 |
GAB-003 | 2.7±0.8 | 3.3±1.5 | ND | 14 | 85.2±7.2 | 13.9±0.6 |
GAB-004 | 2.2±1.1 | NB | ND | 81 | 66.6±4.6 | 19.4±2.9 |
GAB-005 | NB | NB | ND | 6 | IA | IA |
GAB-006 | NB | NB | ND | 16 | ND | 100.8±1.8 |
GAB-007 | 42.3±8.9 | 1.6±0.2 | ND | 53 | 4.6±0.7 | 20.1±4.3 |
GAB-008 | NB | 16.2±1.7 | ND | 8 | IA | 43.2±3.2 |
GAB-009 | NB | NB | ND | 38 | 162.9±6.0 | 97.6±6.1 |
GAB-010 | NB | 0.12±0.02 | ND | 92 | 66.0±4.4 | 23.8±4.2 |
GAB-011 | NB | NB | ND | 24 | IA | IA |
GAB-012 | NB | NB | 4.58±1.72 | 43 | IA | 119.2±3.6 |
GAB-013 | NB | NB | 6.27±1.16 | 27 | IA | IA |
GAB-014 | NB | NB | NB | 42 | 69.9±0.1** | 177.5±3.9 |
GAB-015 | 13.1±1.5* | 0.05 | 5.0±0.4* | 77 | 71.7±1.6 | 125.4±5.4 |
GAB-016 | 0.9±0.1 | 0.15 | 4.3±0.1* | 96 | 79.0±1.1 | 45.9±1.6 |
GAB-017 | 0.68±0.03 | 0.05 | 18.9±1.2* | 82 | 40.6±0.8 | 41.4±2.7 |
GAB-018 | 36.6±5.0* | NB | 6.0±1.0* | 71 | 85.3±1.5 | 185.4±2.5 |
GAB-019 | ND | ND | ND | 91 | ND | 39.4±6.2 |
GAB-020 | 1.33±4.5 | ND | 2.4±0.6* | 87 | ND | 68.2±5.5 |
DPIEL | 2.8 | ND | 5.04±0.48 | 72 | ND | 30.6±4.3 |
IP4 | ND | ND | 3.08±0.49 | ND | ND | ND |
*Ki measurement.
**MDA-MB-468 cell line used.
ND: Not Determined. NB: No Binding. IA: Inactive.